SUBSCRIBE
SUBSCRIBE
News   Policy

Teva Pharmaceutical Industries Limited Sues Novartis AG, Momenta Pharmaceuticals, Inc. Over Copaxone Patent

August 29, 2008 | 
1 min read
NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd sued Swiss drugmaker Novartis AG and Momenta Pharmaceuticals Inc on Thursday, accusing them of infringing patents on its multiple sclerosis drug Copaxone.
Legal
Novartis
MORE ON THIS TOPIC
3D Illustration of unlucky business man under rain, surreal concept
Vaccines
Vaccine Investors Keep Their Heads Down as Trump Cuts Shot Schedule
January 6, 2026
 · 
3 min read
 · 
Dan Samorodnitsky
Pleasanton, CA, USA - Feb 21, 2024: Exterior view of the headquarters of Roche Molecular Diagnostics (RMD) in Pleasanton, California. F. Hoffmann-La Roche AG is a Swiss pharmaceutical company.
Obesity
Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement
January 6, 2026
 · 
2 min read
 · 
Tristan Manalac
Abstract creative financial graph with finger clicks on a digital tablet on background, forex and investment concept.
Legal
Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme
December 23, 2025
 · 
2 min read
 · 
Nick Paul Taylor
Money or health. Scale of balance between money, dollar and medicine, pill. Cost of health. Compare of price healthcare and healthy. Seesaw between wealth and healthy. Treatment or savings. Vector.
Drug pricing
Trump Administration Reaches Pricing Agreements With 9 More Drugmakers
December 22, 2025
 · 
2 min read
 · 
Nick Paul Taylor